You are here

Home > Current news > News > Companies

Companies

BioRegió Desembre

HIGHLIGHTS: Innovative pharma, new biotech milestones, Catalan research in ‘Nature’ and ‘Lancet’

20.12.2017

New licenses, business plans, clinical studies and papers in the BioRegion this December

CataloniaBioHT

CataloniaBio and HealthTech Cluster merge into an association that will represent more than 170 companies

14.12.2017

The call for elections to choose the board of directors will open on 9 January

 

 

LessonsLearned

Biopharma and medtech, growing convergence to tackle global health challenges

05.12.2017

The line between these two areas has become blurred and is taking us towards a new business model

Missio Adelaida

Companies from the BioRegion join reverse mission from Australian region of Adelaide

11.12.2017

The event was promoted by Biocat under the framework of the bioXclusters plus internationalization project

MissioToyama

Third-largest pharmaceutical association in Japan seeks partners in Catalonia

05.12.2017

The Toyama Pharmaceutical Association visited the BioRegion on an ICEX reverse mission with collaboration from Biocat 

20ForumHealthcare

Nine companies from the BioRegion seek investors at Healthcare Investment Forum

01.12.2017

This event promoted by the Barcelona Medical Association, Barcelona Activa, Biocat and ESADE BAN is now in its 20th edition

HIGHLIGHTS: EMA location, new leaders for EIT Health, news from Grifols and Reig Jofre, new investment fund and advances in research

28.11.2017

Barcelona will not host the European Medicines Agency, but the BioRegion of Catalonia is still one of the leading regions in healthcare & life sciences

La BioRegió a l'octubre

HIGHLIGHTS: The BioRegion in ‘Nature’, record investment, corporate headquarters moved and advances in oncology

30.10.2017

Moves of legal HQ due to political situation leave a bittersweet taste in a month full of good news for the sector

Presentació estudi CataloniaBio i EY

Biomedical companies in Catalonia attracted €153 millions in private investment in 2016

11.10.2017

Most of the funding comes from inside Catalonia, through venture capital funds, licensing deals and business angels and family offices, according to study from CataloniaBio and EY

BIO Japan 2017

Seven Catalan companies scout for new partners in Japan on mission organized by Biocat and ACCIÓ

17.10.2017

Cytes Biotechnologies, Creatio, Gebro Pharma, Readycell, Laboratorios Rubió, Thrombotargets Europe and ZeClinics participated in BioJapan

Developed by Drauta